FDA
-
-
-
-
-
-
-
Orchestra BioMed targets BACKBEAT trial completion by Q3 2026
-
-
-
-
-
-
-
Medtronic receives CE mark for Stealth AXiS surgical system in Europe
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)
-
-
-
-
-
-
-
Medtronic receives FDA clearance for spine surgery robotic system
-
-
-
-
-
-
-
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
-
-
-
-
-
-
-
Medtronic, Inc. (MDT) PT Raised to $111 at Bernstein Following 'Strong Q'
-
-
-
-
-
-
-
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

